Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children

Andrew M. Developmental hemostasis: relevance to hemostatic problems during childhood. Semin Thromb Hemost. 1995;21(4):341–56.

Article  CAS  PubMed  Google Scholar 

Toulon P. Developmental hemostasis: laboratory and clinical implications. Int J Lab Hematol. 2016;38(Suppl 1):66–77.

Article  PubMed  Google Scholar 

Attard C, van der Straaten T, Karlaftis V, Monagle P, Ignjatovic V. Developmental hemostasis: age-specific differences in the levels of hemostatic proteins. J Thromb Haemost. 2013;11(10):1850–4.

Article  CAS  PubMed  Google Scholar 

Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. 2010;24(2):63–8.

Article  CAS  PubMed  Google Scholar 

Rey Y, Formoso V, Barreto Mota R, Soares H. Developmental hemostasis in the neonatal period. World J Pediatr. 2022;18(1):7–15.

Article  Google Scholar 

Araki S, Shirahata A. Vitamin K deficiency bleeding in infancy. Nutrients. 2020;12(3):780.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eliwan H, Omer M, McKenna E, Kelly LA, Nolan B, Regan I, et al. Protein C pathway in paediatric and neonatal Sepsis. Front Pediatr. 2022;9: 562495.

Article  PubMed  PubMed Central  Google Scholar 

Ohga S, Kang D, Kinjo T, Ochiai M, Doi T, Ishimura M, et al. Paediatric presentation and outcome of congenital protein C deficiency in Japan. Haemophilia. 2013;19(3):378–84.

Article  CAS  PubMed  Google Scholar 

Toulon P, Smirnov M, Triscott M, Safa O, Biguzzi E, Bouziane K, et al. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study. Thromb Res. 2009;124(1):137–43.

Article  CAS  PubMed  Google Scholar 

Ruzicka K, Kapiotis S, Quehenberger P, Handler S, Pabinger-Fasching I, Mannhalter C, et al. Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway. Thromb Res. 1997;87(6):501–10.

Article  CAS  PubMed  Google Scholar 

Hashimoto N, Ogiwara K, Shimonishi N, Nakagawa T, Nakajima Y, Furukawa S, et al. Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis. Eur J Haematol. 2022;109(1):100–8.

Article  CAS  PubMed  Google Scholar 

Aoki H, Ogiwara K, Hasegawa M, Nogami K. Hemostatic rebalance in neonatal intrahepatic cholestasis with citrin deficiency. Pediatr Int. 2022;64(1): e14741.

Article  PubMed  Google Scholar 

Ogiwara K, Nogami K, Mizumachi K, Nakagawa T, Noda N, Ohga S, et al. Hemostatic assessment of combined anticoagulant therapy using warfarin and prothrombin complex concentrates in a case of severe protein C deficiency. Int J Hematol. 2019;109(6):650–6.

Article  CAS  PubMed  Google Scholar 

Rogalski P, Rogalska-Plonska M, Wroblewski E, Kostecka-Roslen I, Dabrowska M, Swidnicka-Siergiejko A, et al. Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding. Thromb Res. 2019;178:41–6.

Article  CAS  PubMed  Google Scholar 

Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: a British Society for Haematology guideline. Br J Haematol. 2022;198(3):443–58.

Article  PubMed  PubMed Central  Google Scholar 

Hashimoto N, Ogiwara K, Matsumoto T, Furukawa S, Takeyama M, Nogami K. Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays. Blood Coagul Fibrinolysis. 2022;33(6):327–36.

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif